Baicalin Alleviates Acute Lung Injury by Activating the SIRT3/GPX4 Pathway to Inhibit Lung Epithelial Cell Ferroptosis.

IF 1 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY
Tengfei Du, Qijia Feng
{"title":"Baicalin Alleviates Acute Lung Injury by Activating the SIRT3/GPX4 Pathway to Inhibit Lung Epithelial Cell Ferroptosis.","authors":"Tengfei Du, Qijia Feng","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study was carried out with the objective of investigating the effect of baicalin (BA) on ferroptosis in acute lung injury (ALI) and elucidating BA's underlying mechanism during this process.</p><p><strong>Methods: </strong>ALI was induced in mice with lipopolysaccharide (LPS), and BA was subsequently administered once daily for seven consecutive days. Lung injury severity was assessed via the lung wet-to-dry weight ratio (W/D ratio) calculation. Enzyme-linked immunosorbent assay (ELISA) was employed for determining inflammatory factor levels in bronchoalveolar lavage fluid (BALF). Histopathological lung tissue variations were examined through hematoxylin-eosin (HE) staining. Myeloperoxidase (MPO) activity was also evaluated in lung tissues. <i>In vitro</i>, ALI was simulated via the exposure of BEAS-2B to LPS for 24 h before BA treatment. The ferroptosis agonist Erastin or Sirtuin 3 (SIRT3) inhibitor 3-TYP were administered to cells for 1 h. CCK-8 assay and flow cytometry were respectively adopted for assessing cell survival and death. Ferroptosis-linked markers, like reactive oxygen species (ROS), malondialdehyde (MDA), reduced glutathione (GSH), as well as ferrous iron (Fe<sup>2+</sup>), were respectively quantified, along with the protein expression of glutathione peroxidase 4 (GPX4). SIRT3 protein expression was analyzed through Western blot (WB).</p><p><strong>Results: </strong>Animal experiments showed that BA notably lowered the lung injury score (LIS), W/D ratio, MPO activity in lung tissue, and IL-1β, IL-6, and TNF-α levels in BALF (<i>P</i><0.05). Moreover, BA lowered ROS, MDA, and Fe<sup>2+</sup> levels in lung tissue (<i>P</i><0.01), and elevated GSH content and the expression of GPX4 and SIRT3 (<i>P</i><0.01). Similarly, <i>in vitro</i> experiments further confirmed that BA attenuated LPS-induced cellular injury and ferroptosis in BEAS-2B cells. However, Erastin and 3-TYP markedly reduced BA's ability to protect BEAS-2B cells from LPS-induced ferroptosis.</p><p><strong>Conclusion: </strong>BA ameliorates LPS-triggered ALI through ferroptosis suppression in lung epithelial cells via the SIRT3/GPX4 pathway.</p>","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":"55 4","pages":"556-566"},"PeriodicalIF":1.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of clinical and laboratory science","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study was carried out with the objective of investigating the effect of baicalin (BA) on ferroptosis in acute lung injury (ALI) and elucidating BA's underlying mechanism during this process.

Methods: ALI was induced in mice with lipopolysaccharide (LPS), and BA was subsequently administered once daily for seven consecutive days. Lung injury severity was assessed via the lung wet-to-dry weight ratio (W/D ratio) calculation. Enzyme-linked immunosorbent assay (ELISA) was employed for determining inflammatory factor levels in bronchoalveolar lavage fluid (BALF). Histopathological lung tissue variations were examined through hematoxylin-eosin (HE) staining. Myeloperoxidase (MPO) activity was also evaluated in lung tissues. In vitro, ALI was simulated via the exposure of BEAS-2B to LPS for 24 h before BA treatment. The ferroptosis agonist Erastin or Sirtuin 3 (SIRT3) inhibitor 3-TYP were administered to cells for 1 h. CCK-8 assay and flow cytometry were respectively adopted for assessing cell survival and death. Ferroptosis-linked markers, like reactive oxygen species (ROS), malondialdehyde (MDA), reduced glutathione (GSH), as well as ferrous iron (Fe2+), were respectively quantified, along with the protein expression of glutathione peroxidase 4 (GPX4). SIRT3 protein expression was analyzed through Western blot (WB).

Results: Animal experiments showed that BA notably lowered the lung injury score (LIS), W/D ratio, MPO activity in lung tissue, and IL-1β, IL-6, and TNF-α levels in BALF (P<0.05). Moreover, BA lowered ROS, MDA, and Fe2+ levels in lung tissue (P<0.01), and elevated GSH content and the expression of GPX4 and SIRT3 (P<0.01). Similarly, in vitro experiments further confirmed that BA attenuated LPS-induced cellular injury and ferroptosis in BEAS-2B cells. However, Erastin and 3-TYP markedly reduced BA's ability to protect BEAS-2B cells from LPS-induced ferroptosis.

Conclusion: BA ameliorates LPS-triggered ALI through ferroptosis suppression in lung epithelial cells via the SIRT3/GPX4 pathway.

黄芩苷通过激活SIRT3/GPX4通路抑制肺上皮细胞铁沉减轻急性肺损伤
目的:探讨黄芩苷(baicalin, BA)对急性肺损伤(ALI)大鼠铁上吊的影响,并阐明其作用机制。方法:用脂多糖(LPS)诱导小鼠ALI, BA每天1次,连续7 d。通过计算肺干湿重比(W/D ratio)评估肺损伤严重程度。采用酶联免疫吸附试验(ELISA)测定支气管肺泡灌洗液(BALF)中炎症因子水平。苏木精-伊红(HE)染色检测肺组织病理变化。髓过氧化物酶(MPO)活性也在肺组织中进行了评估。在体外,通过在BA处理前将BEAS-2B暴露于LPS 24 h来模拟ALI。细胞给予铁凋亡激动剂Erastin或Sirtuin 3 (SIRT3)抑制剂3- typ 1 h,分别采用CCK-8法和流式细胞术检测细胞存活和死亡情况。分别定量了与铁中毒相关的标志物,如活性氧(ROS)、丙二醛(MDA)、还原性谷胱甘肽(GSH)和亚铁(Fe2+),以及谷胱甘肽过氧化物酶4 (GPX4)的蛋白表达。Western blot (WB)检测SIRT3蛋白表达。结果:动物实验显示,BA可显著降低肺损伤评分(LIS)、W/D比、肺组织MPO活性以及肺组织BALF (P2+)中IL-1β、IL-6、TNF-α水平(PPin体外实验进一步证实BA可减轻lps诱导的BEAS-2B细胞损伤和铁凋亡。然而,Erastin和3-TYP显著降低了BA保护BEAS-2B细胞免受lps诱导的铁凋亡的能力。结论:BA通过SIRT3/GPX4通路抑制肺上皮细胞铁凋亡,改善lps触发的ALI。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of clinical and laboratory science
Annals of clinical and laboratory science 医学-医学实验技术
CiteScore
1.60
自引率
0.00%
发文量
112
审稿时长
6-12 weeks
期刊介绍: The Annals of Clinical & Laboratory Science welcomes manuscripts that report research in clinical science, including pathology, clinical chemistry, biotechnology, molecular biology, cytogenetics, microbiology, immunology, hematology, transfusion medicine, organ and tissue transplantation, therapeutics, toxicology, and clinical informatics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信